Title	Publication Date	Language	Citations
Vascular Cognitive Impairment (VCI)	2022/01/01	English	71
Autoimmune Epilepsy	2019/07/01	English	71
Tardive Dyskinesia: Therapeutic Options for an Increasingly Common Disorder	2014/01/01	English	71
The Therapy of Congenital Myasthenic Syndromes	2007/04/01	English	71
CGRP Receptor Antagonism and Migraine	2010/04/01	English	70
Neuropathic Pain and Deep Brain Stimulation	2014/07/01	English	70
Epigenetics, Autism Spectrum, and Neurodevelopmental Disorders	2013/10/01	English	70
Botanicals and Herbs: A Traditional Approach to Treating Epilepsy	2009/04/01	English	69
What Happened to Posteroventral Pallidotomy for Parkinson’s Disease and Dystonia?	2008/04/01	English	69
Cell Death and Recovery in Traumatic Brain Injury	2020/04/01	English	68
Resveratrol Improves Motoneuron Function and Extends Survival in SOD1G93A ALS Mice	2014/04/01	English	68
Directional Deep Brain Stimulation	2019/01/01	English	68
Deep Brain Stimulation and Tremor	2008/04/01	English	68
Enhancing Rehabilitative Therapies with Vagus Nerve Stimulation	2016/04/01	English	68
Animal Models of Neurologic Disorders: A Nonhuman Primate Model of Spinal Cord Injury	2012/04/01	English	67
Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model	2020/01/01	English	67
Exercise for Brain Health: An Investigation into the Underlying Mechanisms Guided by Dose	2019/07/01	English	67
Origins of Temporal Lobe Epilepsy: Febrile Seizures and Febrile Status Epilepticus	2014/04/01	English	67
Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action	2018/04/01	English	66
Stiripentol	2007/01/01	English	66
Matrix Metalloproteinases in Acute Intracerebral Hemorrhage	2020/04/01	English	66
Transcranial Direct Current Stimulation Enhances Recovery of Stereopsis in Adults With Amblyopia	2013/10/01	English	66
Acetyltransferases (HATs) as Targets for Neurological Therapeutics	2013/10/01	English	66
Episodic Ataxia Type 1: A Neuronal Potassium Channelopathy	2007/04/01	English	65
Urate as a Marker of Risk and Progression of Neurodegenerative Disease	2017/01/01	English	65
The Role of the Gut Microbiome in Multiple Sclerosis Risk and Progression: Towards Characterization of the “MS Microbiome”	2018/01/01	English	65
Ginsenoside Rd in Experimental Stroke: Superior Neuroprotective Efficacy with a Wide Therapeutic Window	2011/07/01	English	65
The Potential of Antiseizure Drugs and Agents that Act on Novel Molecular Targets as Antiepileptogenic Treatments	2014/04/01	English	65
Novel mGluR5 Positive Allosteric Modulator Improves Functional Recovery, Attenuates Neurodegeneration, and Alters Microglial Polarization after Experimental Traumatic Brain Injury	2014/10/01	English	64
Targeted 5-HT1F Therapies for Migraine	2018/04/01	English	64